Clinical trials
Phase 4 Heart Defects, Congenital trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 2 |
| Stanford University | 2 |
| Anita Saraf | 1 |
| Boston Children's Hospital | 1 |
| Duke University | 1 |
| Nicklaus Children's Hospital f/k/a Miami Children's Hospital | 1 |
| Phoenix Children's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Defects, Congenital | 9 |
| Afibrinogenemia | 1 |
| Agnosia | 1 |
| Aortic Valve Disease | 1 |
| Duodenal Ulcer | 1 |
| Gastrointestinal Hemorrhage | 1 |
| Heart Failure | 1 |
| Hemostatic Disorders | 1 |
| Infections | 1 |
| Rubinstein-Taybi Syndrome | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.